BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31184642)

  • 1. Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles.
    Hu Y; Zhang HR; Dong L; Xu MR; Zhang L; Ding WP; Zhang JQ; Lin J; Zhang YJ; Qiu BS; Wei PF; Wen LP
    Nanoscale; 2019 Jun; 11(24):11789-11807. PubMed ID: 31184642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
    Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ
    Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc oxide nanoparticles harness autophagy to induce cell death in lung epithelial cells.
    Zhang J; Qin X; Wang B; Xu G; Qin Z; Wang J; Wu L; Ju X; Bose DD; Qiu F; Zhou H; Zou Z
    Cell Death Dis; 2017 Jul; 8(7):e2954. PubMed ID: 28749469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exposure to ZnO nanoparticles induces autophagic immune cell death.
    Johnson BM; Fraietta JA; Gracias DT; Hope JL; Stairiker CJ; Patel PR; Mueller YM; McHugh MD; Jablonowski LJ; Wheatley MA; Katsikis PD
    Nanotoxicology; 2015; 9(6):737-48. PubMed ID: 25378273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
    Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
    ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of multidrug-resistant malignant cells by liposomes co-encapsulating doxorubicin and chloroquine through autophagic inhibition.
    Gao M; Xu Y; Qiu L
    J Liposome Res; 2017 Jun; 27(2):151-160. PubMed ID: 27250110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-triggered selective ROS-dependent autophagy by bioactive nanoliposomes for efficient cancer theranostics.
    Appidi T; Pemmaraju DB; Khan RA; Alvi SB; Srivastava R; Pal M; Khan N; Rengan AK
    Nanoscale; 2020 Jan; 12(3):2028-2039. PubMed ID: 31912859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc oxide nanoparticles effectively regulate autophagic cell death by activating autophagosome formation and interfering with their maturation.
    Liu Z; Lv X; Xu L; Liu X; Zhu X; Song E; Song Y
    Part Fibre Toxicol; 2020 Sep; 17(1):46. PubMed ID: 32948194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.
    Xie Z; Guo W; Guo N; Huangfu M; Liu H; Lin M; Xu W; Chen J; Wang T; Wei Q; Han M; Gao J
    Acta Biomater; 2018 Apr; 71():351-362. PubMed ID: 29545193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-mediated chemosensitization by cysteamine in cancer cells.
    Wan XM; Zheng F; Zhang L; Miao YY; Man N; Wen LP
    Int J Cancer; 2011 Sep; 129(5):1087-95. PubMed ID: 21080439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal.
    Zhang Q; Yang W; Man N; Zheng F; Shen Y; Sun K; Li Y; Wen LP
    Autophagy; 2009 Nov; 5(8):1107-17. PubMed ID: 19786831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agent.
    Wiesmann N; Kluenker M; Demuth P; Brenner W; Tremel W; Brieger J
    J Trace Elem Med Biol; 2019 Jan; 51():226-234. PubMed ID: 30115501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation.
    Yan J; Dou X; Zhou J; Xiong Y; Mo L; Li L; Lei Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):353. PubMed ID: 31412953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance.
    Xu M; Hu Y; Ding W; Li F; Lin J; Wu M; Wu J; Wen LP; Qiu B; Wei PF; Li P
    Biomaterials; 2020 Nov; 258():120308. PubMed ID: 32841911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
    Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
    Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-loaded titanium dioxide nanoparticle coated with tumor targeting polymer as a sonodynamic chemotherapeutic agent for anti-cancer therapy.
    Kim S; Im S; Park EY; Lee J; Kim C; Kim TI; Kim WJ
    Nanomedicine; 2020 Feb; 24():102110. PubMed ID: 31666202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.
    Hu JJ; Lei Q; Peng MY; Zheng DW; Chen YX; Zhang XZ
    Biomaterials; 2017 Jun; 128():136-146. PubMed ID: 28325685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of metal oxide nanoparticles for the delivery of anticancer drug.
    Sharma H; Kumar K; Choudhary C; Mishra PK; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(2):672-9. PubMed ID: 25406734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
    Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
    Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.